ALLISON DUNIVAN: Open Payments
NPI 1972022192 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,283 in 61 payments from 15 companies in 2025. Trend: 2023 $1,500 · 2024 $790 · 2025 $1,283
Food & beverage: $1,176Education: $107
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $296 |
| Verona Pharma, Inc. | 10 | $173 |
| GENZYME CORPORATION | 7 | $169 |
| AstraZeneca Pharmaceuticals LP | 7 | $161 |
| SK Life Science, Inc. | 5 | $123 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $72 |
| Insmed, Inc. | 3 | $53 |
| UCB, Inc. | 1 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
Products named: DUPIXENT, NUCALA, Ohtuvayre, TRELEGY ELLIPTA, BREZTRI, OFEV, Arikayce, AIRSUPRA.
Industry payments across CA — which companies pay providers there.
